Recent progress in China’s radiopharmaceuticals
10.11665/j.issn.1000-5048.2026060101
- VernacularTitle:我国核药研究进展
- Author:
Kuan HU
1
;
Xin GAO
;
Rui WANG
Author Information
1. 中国医学科学院北京协和医学院药物研究所, 天然药物及核药基础与新药创制全国重点实验室，北京100050
- Publication Type:Journal Article
- Keywords:
radiopharmaceuticals;
medical isotopes;
molecular imaging;
tumor targets;
clinical trials
- From:
Journal of China Pharmaceutical University
2026;57(4):534-539
- CountryChina
- Language:Chinese
-
Abstract:
Radiopharmaceuticals play an indispensable role in the precise diagnosis and treatment of major diseases. Based on the latest regulations and policies related to radiopharmaceuticals issued in China in 2024, relevant literature published by Chinese researchers in domestic and international journals, and the latest clinical research developments in China, this review systematically summarizes the major advances in radiopharmaceutical research in China. It covers the analysis of relevant policies and regulations, breakthroughs in basic research, developments in clinical research, and the latest R&D advances made by Chinese radiopharmaceutical companies. Finally, the future prospects of China’s radiopharmaceutical field are discussed.
